##gff-version 3
##sequence-region Q12879 1 1464
Q12879	UniProtKB	Signal peptide	1	22	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Chain	23	1464	.	.	.	ID=PRO_0000011573;Note=Glutamate receptor ionotropic%2C NMDA 2A	
Q12879	UniProtKB	Topological domain	23	555	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Transmembrane	556	576	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Topological domain	577	600	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Intramembrane	601	620	.	.	.	Note=Discontinuously helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Topological domain	621	625	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Transmembrane	626	645	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Topological domain	646	816	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Transmembrane	817	837	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Topological domain	838	1464	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Region	511	513	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5H8F,ECO:0000244|PDB:5H8H,ECO:0000244|PDB:5H8N,ECO:0000244|PDB:5H8Q,ECO:0000244|PDB:5I2K,ECO:0000244|PDB:5I2N,ECO:0000244|PDB:5KCJ,ECO:0000244|PDB:5KDT,ECO:0000244|PDB:5TP9,ECO:0000244|PDB:5TPA,ECO:0000269|PubMed:26875626,ECO:0000269|PubMed:26919761,ECO:0000269|PubMed:28105280;Dbxref=PMID:26875626,PMID:26919761,PMID:28105280	
Q12879	UniProtKB	Region	599	620	.	.	.	Note=Pore-forming;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:B7ZSK1	
Q12879	UniProtKB	Region	689	690	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Region	730	731	.	.	.	Note=Glutamate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Motif	1462	1464	.	.	.	Note=PDZ-binding;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q12879	UniProtKB	Metal binding	44	44	.	.	.	Note=Zinc%3B via tele nitrogen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Metal binding	128	128	.	.	.	Note=Zinc%3B via tele nitrogen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Metal binding	266	266	.	.	.	Note=Zinc;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Metal binding	282	282	.	.	.	Note=Zinc;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Binding site	518	518	.	.	.	Note=Glutamate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5H8F,ECO:0000244|PDB:5H8H,ECO:0000244|PDB:5H8N,ECO:0000244|PDB:5H8Q,ECO:0000244|PDB:5I2K,ECO:0000244|PDB:5I2N,ECO:0000244|PDB:5KCJ,ECO:0000244|PDB:5KDT,ECO:0000244|PDB:5TP9,ECO:0000244|PDB:5TPA,ECO:0000269|PubMed:26875626,ECO:0000269|PubMed:26919761,ECO:0000269|PubMed:28105280;Dbxref=PMID:26875626,PMID:26919761,PMID:28105280	
Q12879	UniProtKB	Site	614	614	.	.	.	Note=Functional determinant of NMDA receptors;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q12879	UniProtKB	Modified residue	882	882	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P35436	
Q12879	UniProtKB	Modified residue	890	890	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P35436	
Q12879	UniProtKB	Modified residue	929	929	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P35436	
Q12879	UniProtKB	Modified residue	1025	1025	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Modified residue	1059	1059	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P35436	
Q12879	UniProtKB	Modified residue	1062	1062	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Modified residue	1198	1198	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Modified residue	1291	1291	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Glycosylation	75	75	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Glycosylation	340	340	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Glycosylation	380	380	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Glycosylation	443	443	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Glycosylation	444	444	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Glycosylation	541	541	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q12879	UniProtKB	Disulfide bond	87	320	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Disulfide bond	429	455	.	.	.	Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5H8F,ECO:0000244|PDB:5H8H,ECO:0000244|PDB:5H8N,ECO:0000244|PDB:5H8Q,ECO:0000244|PDB:5I2K,ECO:0000244|PDB:5I2N,ECO:0000244|PDB:5KCJ,ECO:0000244|PDB:5KDT,ECO:0000244|PDB:5TP9,ECO:0000244|PDB:5TPA,ECO:0000269|PubMed:26875626,ECO:0000269|PubMed:26919761,ECO:0000269|PubMed:28105280;Dbxref=PMID:26875626,PMID:26919761,PMID:28105280	
Q12879	UniProtKB	Disulfide bond	436	456	.	.	.	Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:5H8F,ECO:0000244|PDB:5H8H,ECO:0000244|PDB:5H8N,ECO:0000244|PDB:5H8Q,ECO:0000244|PDB:5I2K,ECO:0000244|PDB:5I2N,ECO:0000244|PDB:5KCJ,ECO:0000244|PDB:5KDT,ECO:0000244|PDB:5TP9,ECO:0000244|PDB:5TPA,ECO:0000269|PubMed:26875626,ECO:0000269|PubMed:26919761,ECO:0000269|PubMed:28105280;Dbxref=PMID:26875626,PMID:26919761,PMID:28105280	
Q12879	UniProtKB	Disulfide bond	745	800	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00959	
Q12879	UniProtKB	Alternative sequence	1259	1464	.	.	.	ID=VSP_044300;Note=In isoform 2. NPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV->MTNAWLLGDAPRTLTNTRCHPRR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q12879	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_067725;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_070345;Note=In FESD. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=dbSNP:rs1250662891,PMID:23933819	
Q12879	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_079929;Note=Found in a patient with autism spectrum disorder%3B unknown pathological significance. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
Q12879	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_067726;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation%3B also found in a patient with benign epilepsy with centrotemporal spike. F->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21499247,ECO:0000269|PubMed:23933819;Dbxref=dbSNP:rs587780353,PMID:21499247,PMID:23933819	
Q12879	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_070346;Note=In FESD%3B unknown pathological significance. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933820;Dbxref=PMID:23933820	
Q12879	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_079930;Note=Found in a patient with schizophrenia%3B unknown pathological significance. T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs1377082706,PMID:22833210	
Q12879	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_070347;Note=In FESD%3B unknown pathological significance. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=PMID:23933819	
Q12879	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_070348;Note=In FESD%3B results in reduced high-affinity zinc mediated inhibition. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=PMID:23933819	
Q12879	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_067727;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs868215122,PMID:21499247	
Q12879	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_010938;Note=K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8061049;Dbxref=PMID:8061049	
Q12879	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_067728;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs148531310,PMID:21499247	
Q12879	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_070349;Note=In FESD. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=dbSNP:rs199528312,PMID:23933819	
Q12879	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_070350;Note=In FESD%3B unknown pathological significance. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933820;Dbxref=dbSNP:rs568484876,PMID:23933820	
Q12879	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_079931;Note=P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs148511104,PMID:22833210	
Q12879	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_071624;Note=Found in a cutaneous malignant melanoma sample. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24455489;Dbxref=PMID:24455489	
Q12879	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_070351;Note=In FESD. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=dbSNP:rs761168789,PMID:23933819	
Q12879	UniProtKB	Natural variant	371	371	.	.	.	ID=VAR_067729;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs149344082,PMID:21499247	
Q12879	UniProtKB	Natural variant	373	373	.	.	.	ID=VAR_067730;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	380	380	.	.	.	ID=VAR_078109;Note=Found in a patient with neonatal onset epileptic encephalopathy%3B unknown pathological significance. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27864847;Dbxref=dbSNP:rs1057519551,PMID:27864847	
Q12879	UniProtKB	Natural variant	436	436	.	.	.	ID=VAR_070352;Note=In FESD%3B decreased protein abundance%3B loss of localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency and decreased glycine potency. C->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_067731;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs139033056,PMID:21499247	
Q12879	UniProtKB	Natural variant	452	452	.	.	.	ID=VAR_079932;Note=No effect on localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22833210,ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs145956175,PMID:22833210,PMID:27839871	
Q12879	UniProtKB	Natural variant	459	459	.	.	.	ID=VAR_067732;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	483	483	.	.	.	ID=VAR_070353;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933820,PMID:27839871	
Q12879	UniProtKB	Natural variant	504	504	.	.	.	ID=VAR_070354;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B no significant effect on calcium ion transmembrane import into cytosol. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs1360906241,PMID:23933820,PMID:27839871	
Q12879	UniProtKB	Natural variant	506	506	.	.	.	ID=VAR_079933;Note=In FESD%3B no effect on localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs796052543,PMID:27839871	
Q12879	UniProtKB	Natural variant	518	518	.	.	.	ID=VAR_070355;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by affected receptor kinetics. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs397518470,PMID:23933820,PMID:27839871	
Q12879	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_070356;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by affected receptor kinetics. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933818,ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs397518468,PMID:23933818,PMID:27839871	
Q12879	UniProtKB	Natural variant	547	547	.	.	.	ID=VAR_070357;Note=In FESD. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=PMID:23933819	
Q12879	UniProtKB	Natural variant	548	548	.	.	.	ID=VAR_070358;Note=In FESD%3B no effect on localization to the cell membrane%3B loss of glutamate-gated calcium ion channel activity. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:28095420;Dbxref=PMID:23933820,PMID:28095420	
Q12879	UniProtKB	Natural variant	552	552	.	.	.	ID=VAR_069382;Note=In FESD%3B no effect on localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency with delay in rise time and slower deactivation time course. P->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23033978,ECO:0000269|PubMed:28095420;Dbxref=dbSNP:rs397518450,PMID:23033978,PMID:28095420	
Q12879	UniProtKB	Natural variant	576	576	.	.	.	ID=VAR_079934;Note=F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
Q12879	UniProtKB	Natural variant	595	595	.	.	.	ID=VAR_067733;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs551688681,PMID:21499247	
Q12879	UniProtKB	Natural variant	598	598	.	.	.	ID=VAR_067734;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	615	615	.	.	.	ID=VAR_065899;Note=In FESD%3B the mutant receptor has decreased calcium permeability%3B shows a dominant-negative effect. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20890276;Dbxref=dbSNP:rs397518447,PMID:20890276	
Q12879	UniProtKB	Natural variant	649	649	.	.	.	ID=VAR_069383;Note=In FESD. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23033978;Dbxref=dbSNP:rs397514557,PMID:23033978	
Q12879	UniProtKB	Natural variant	652	652	.	.	.	ID=VAR_070359;Note=In FESD%3B affects receptor kinetics. F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933820;Dbxref=dbSNP:rs397518471,PMID:23933820	
Q12879	UniProtKB	Natural variant	653	653	.	.	.	ID=VAR_067735;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	669	669	.	.	.	ID=VAR_070360;Note=In FESD%3B no effect on localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency. K->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933820,PMID:27839871	
Q12879	UniProtKB	Natural variant	685	685	.	.	.	ID=VAR_079935;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency. V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs796052548,PMID:27839871	
Q12879	UniProtKB	Natural variant	694	694	.	.	.	ID=VAR_070361;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933820,PMID:27839871	
Q12879	UniProtKB	Natural variant	699	699	.	.	.	ID=VAR_070362;Note=In FESD%3B no effect on localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency and decreased open probability. P->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	705	705	.	.	.	ID=VAR_070363;Note=In FESD%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability. M->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	712	712	.	.	.	ID=VAR_067736;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs143031592,PMID:21499247	
Q12879	UniProtKB	Natural variant	714	714	.	.	.	ID=VAR_070364;Note=In FESD%3B decreased protein abundance%3B no effect on localization to the cell membrane%3B no significant effect on calcium ion transmembrane import into cytosol. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	716	716	.	.	.	ID=VAR_078110;Note=In FESD%3B unknown pathological significance. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27864847;Dbxref=dbSNP:rs1057519552,PMID:27864847	
Q12879	UniProtKB	Natural variant	716	716	.	.	.	ID=VAR_070365;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871;Dbxref=dbSNP:rs762659685,PMID:23933820,PMID:27839871	
Q12879	UniProtKB	Natural variant	727	727	.	.	.	ID=VAR_070366;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	731	731	.	.	.	ID=VAR_070367;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B decreased glutamate-gated calcium ion channel activity characterized by drastically decreased glutamate agonist potency%2C decreased glycine agonist potency%2C reduced amplitude of current response%2C shortened synaptic-like response time course%2C decreased channel open probability and enhanced sensitivity to negative allosteric modulators. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27839871,ECO:0000269|PubMed:28182669;Dbxref=dbSNP:rs796052549,PMID:23933820,PMID:27839871,PMID:28182669	
Q12879	UniProtKB	Natural variant	734	734	.	.	.	ID=VAR_070368;Note=In FESD%3B no effect on localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency. V->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	740	740	.	.	.	ID=VAR_067737;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. G->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	762	762	.	.	.	ID=VAR_071625;Note=Found in a cutaneous malignant melanoma sample. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24455489;Dbxref=PMID:24455489	
Q12879	UniProtKB	Natural variant	772	772	.	.	.	ID=VAR_070369;Note=In FESD%3B decreased protein abundance%3B decreased localization to the cell membrane%3B changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability. K->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23933819,ECO:0000269|PubMed:27839871;Dbxref=PMID:23933819,PMID:27839871	
Q12879	UniProtKB	Natural variant	812	812	.	.	.	ID=VAR_072750;Note=In FESD%3B increase in receptor response to agonists%3B decrease in the actions of endogenous negative modulators%3B increase in channel open probability%3B prolonged deactivation time course. L->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24504326;Dbxref=PMID:24504326	
Q12879	UniProtKB	Natural variant	814	814	.	.	.	ID=VAR_070370;Note=In FESD%3B unknown pathological significance. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=dbSNP:rs780654733,PMID:23933819	
Q12879	UniProtKB	Natural variant	817	817	.	.	.	ID=VAR_071626;Note=In FESD%3B gain-of-function characterized by enhanced agonist potency%2C reduced sensitivity to endogenous negative inhibitors%2C prolonged synaptic-like response time course%2C increased single-channel mean open time and increased channel open probability. M->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24903190,ECO:0000269|PubMed:28126851;Dbxref=dbSNP:rs796052551,PMID:24903190,PMID:28126851	
Q12879	UniProtKB	Natural variant	852	852	.	.	.	ID=VAR_079936;Note=V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs150316865,PMID:22833210	
Q12879	UniProtKB	Natural variant	884	884	.	.	.	ID=VAR_078690;Note=Found in a patient with autism%3B unknown pathological significance. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26637798;Dbxref=dbSNP:rs777684328,PMID:26637798	
Q12879	UniProtKB	Natural variant	889	889	.	.	.	ID=VAR_067738;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. G->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21499247,ECO:0000269|PubMed:24455489;Dbxref=PMID:21499247,PMID:24455489	
Q12879	UniProtKB	Natural variant	904	904	.	.	.	ID=VAR_070371;Note=In FESD. I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=PMID:23933819	
Q12879	UniProtKB	Natural variant	920	920	.	.	.	ID=VAR_067739;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	922	922	.	.	.	ID=VAR_079937;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs200037904,PMID:22833210	
Q12879	UniProtKB	Natural variant	929	929	.	.	.	ID=VAR_067740;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs767268773,PMID:21499247	
Q12879	UniProtKB	Natural variant	933	933	.	.	.	ID=VAR_070372;Note=In FESD%3B unknown pathological significance. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933820;Dbxref=dbSNP:rs933322445,PMID:23933820	
Q12879	UniProtKB	Natural variant	937	937	.	.	.	ID=VAR_079938;Note=D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs769602505,PMID:22833210	
Q12879	UniProtKB	Natural variant	962	962	.	.	.	ID=VAR_067741;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs765370528,PMID:21499247	
Q12879	UniProtKB	Natural variant	968	968	.	.	.	ID=VAR_079939;Note=Probable disease-associated mutation found in a patient with schizophrenia. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=PMID:22833210	
Q12879	UniProtKB	Natural variant	976	976	.	.	.	ID=VAR_070373;Note=In FESD. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933819;Dbxref=dbSNP:rs886039239,PMID:23933819	
Q12879	UniProtKB	Natural variant	989	989	.	.	.	ID=VAR_078111;Note=Found in a patient with neonatal onset epileptic encephalopathy%3B unknown pathological significance. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27864847;Dbxref=dbSNP:rs531782747,PMID:27864847	
Q12879	UniProtKB	Natural variant	998	998	.	.	.	ID=VAR_079940;Note=Found in a patient with schizophrenia%3B unknown pathological significance. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs1258974659,PMID:22833210	
Q12879	UniProtKB	Natural variant	1064	1064	.	.	.	ID=VAR_079941;Note=T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs138809301,PMID:22833210	
Q12879	UniProtKB	Natural variant	1073	1073	.	.	.	ID=VAR_067742;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	1074	1074	.	.	.	ID=VAR_067743;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs867432846,PMID:21499247	
Q12879	UniProtKB	Natural variant	1132	1132	.	.	.	ID=VAR_071627;Note=Found in a cutaneous malignant melanoma sample. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24455489;Dbxref=PMID:24455489	
Q12879	UniProtKB	Natural variant	1133	1133	.	.	.	ID=VAR_071628;Note=Found in a cutaneous malignant melanoma sample. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24455489;Dbxref=PMID:24455489	
Q12879	UniProtKB	Natural variant	1153	1153	.	.	.	ID=VAR_067744;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs267604687,PMID:21499247	
Q12879	UniProtKB	Natural variant	1175	1175	.	.	.	ID=VAR_067745;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs867464241,PMID:21499247	
Q12879	UniProtKB	Natural variant	1229	1229	.	.	.	ID=VAR_079942;Note=Found in a patient with schizophrenia%3B unknown pathological significance. T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22833210;Dbxref=dbSNP:rs747136651,PMID:22833210	
Q12879	UniProtKB	Natural variant	1251	1251	.	.	.	ID=VAR_070374;Note=In FESD. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23933820;Dbxref=PMID:23933820	
Q12879	UniProtKB	Natural variant	1276	1276	.	.	.	ID=VAR_067746;Note=Found in a patient with continuous spike-wave discharges during slow-wave sleep%3B also found in a patient with drug-resistant focal epilepsy%3B also found in a cutaneous malignant melanoma sample as somatic mutation%3B unknown pathological significance. A->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21499247,ECO:0000269|PubMed:22833210,ECO:0000269|PubMed:23933820,ECO:0000269|PubMed:27864847;Dbxref=dbSNP:rs145063086,PMID:21499247,PMID:22833210,PMID:23933820,PMID:27864847	
Q12879	UniProtKB	Natural variant	1285	1285	.	.	.	ID=VAR_067747;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs367543132,PMID:21499247	
Q12879	UniProtKB	Natural variant	1318	1318	.	.	.	ID=VAR_067748;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs774419037,PMID:21499247	
Q12879	UniProtKB	Natural variant	1366	1366	.	.	.	ID=VAR_067749;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	1421	1421	.	.	.	ID=VAR_067750;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Natural variant	1425	1425	.	.	.	ID=VAR_067751;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs976259560,PMID:21499247	
Q12879	UniProtKB	Natural variant	1426	1426	.	.	.	ID=VAR_067752;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=dbSNP:rs138415164,PMID:21499247	
Q12879	UniProtKB	Natural variant	1462	1462	.	.	.	ID=VAR_067753;Note=Found in a cutaneous malignant melanoma sample%3B somatic mutation. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21499247;Dbxref=PMID:21499247	
Q12879	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Changed glutamate-gated calcium ion channel activity characterized by increased desensitization. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q12879	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Changed glutamate-gated calcium ion channel activity characterized by accelerated response activation time and increased desensitization. P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q12879	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Changed glutamate-gated calcium ion channel activity characterized by increased desensitization. P->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q12879	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency with delay in rise time and slower deactivation time course. P->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q12879	UniProtKB	Mutagenesis	552	552	.	.	.	Note=No effect on localization to the cell membrane. Changed glutamate-gated calcium ion channel activity characterized by increased desensitization. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q12879	UniProtKB	Mutagenesis	552	552	.	.	.	Note=No effect on localization to the cell membrane. Changed glutamate-gated calcium ion channel activity characterized by decreased response amplitude and changed desensitization without effect on response rise time or deactivation time course. P->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28095420;Dbxref=PMID:28095420	
Q12879	UniProtKB	Beta strand	405	410	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Turn	414	416	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	417	421	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Turn	424	426	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5KCJ	
Q12879	UniProtKB	Beta strand	434	442	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	449	458	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	459	471	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	474	479	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	482	485	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	487	489	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5I2K	
Q12879	UniProtKB	Beta strand	492	494	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5I2K	
Q12879	UniProtKB	Helix	495	501	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	506	508	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	516	519	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	522	524	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	528	538	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	668	671	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	673	675	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	676	678	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	686	688	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5I2K	
Q12879	UniProtKB	Helix	689	697	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	699	705	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	706	708	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	713	721	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	726	731	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	732	740	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	743	745	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5I2N	
Q12879	UniProtKB	Beta strand	747	750	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Turn	751	753	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	756	761	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	764	766	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5I2K	
Q12879	UniProtKB	Helix	772	784	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Helix	787	795	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5H8F	
Q12879	UniProtKB	Beta strand	1461	1464	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NFL	
